Alnylam Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2007 | — | $199.2M | $105.2M |
| FY2008 | — | $202.1M | $191.8M |
| FY2009 | — | $178.0M | $137.5M |
| FY2010 | — | $158.2M | $74.6M |
| FY2011 | — | $118.0M | $70.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2007 | — | $199.2M | $105.2M |
| FY2008 | — | $202.1M | $191.8M |
| FY2009 | — | $178.0M | $137.5M |
| FY2010 | — | $158.2M | $74.6M |
| FY2011 | — | $118.0M | $70.2M |